Jpmorgan Chase & Co »

Tevogen Bio Hldgs shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7k 9.3k 0.72
2024-03-31 $111 30 3.73

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Tevogen Bio Hldgs

Polar Securities
Portland Global Advisors
Cantor Fitzgerald, L. P.
Geode Capital Management
BlackRock
New York State Common Retirement Fund
Vanguard Group
State Street Corporation
Charles Schwab Investment Management
Citadel Advisors
Alpine Partners VI
Morgan Stanley
Rhumbline Advisers
Two Sigma Securities
Bank of America Corporation

View all funds holding Tevogen Bio Hldgs